Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1632813

The Expression Regulation of recA Gene and Bacterial Class 2 Integron-Associated Genes Induced by Antibiotics

Provisionally accepted
Jinglu  YeJinglu Ye1Qian  SunQian Sun1Qiaoping  WuQiaoping Wu1Jianqiang  XuJianqiang Xu1Ye  YangYe Yang1Rongqing  ZhaoRongqing Zhao1Qingcao  LiQingcao Li1,2*
  • 1The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
  • 2State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Wuhan, China

The final, formatted version of the article will be published soon.

To investigate the effects and mechanisms of common antibiotics induction on the expression of class 2 integron integrase and variable region resistance genes in bacteria, as well as potential structural mutations. Clinical isolates containing non-functional and functional class 2 integrons were selected. Strains containing non-functional or functional class 2 integrons were constructed using isolated DNA templates. These strains were subjected to continuous induction with drug concentrations of 1/2 MIC and 1/4 MIC (ciprofloxacin, ampicillin, and kanamycin) and a concentration of 0.2 μg/ml (mitomycin C) over 8 days. The relative expression levels of relevant genes were measured on days 1, 3, and 8. Drug resistance was assessed before and after induction to identify differences. Finally, the sequence of the non-functional class 2 integron integrase gene was analyzed for structural changes that occurred as a result of induction. All drugs selected increased the relative expression levels of target genes. Significant differences in inductive abilities were observed among the drugs. The 1/2 MIC concentrations were more effective than 1/4 MIC concentrations in increasing the relative expression levels of target genes and enhancing the resistance of the experimental strains. The relative expression levels of recA, intI2, and dfrA1 rose on day 1, peaked on day 3, and slightly declined by day 8. Induced strains exhibited increased resistance to the drugs, with the most significant changes observed in the clinical isolates, particularly concerning CIP resistance. Notably, clinical isolate 7b induced with 1/2 MIC KAN exhibited the loss of one base at position 12bp in the integrase sequence. However, none of the drugs induced mutations at the 444 bp position of class 2 integrons. Sub-MIC concentrations of drugs have been shown to induce an increase in the relative expression level of the SOS response-related gene recA, as well as the integrase and resistance genes of class 2 integrons. Continuous induction leads to sustained upregulation of these genes, which stabilizes or slightly decreases upon reaching a plateau. However, the capacity of different drugs to induce expression varies significantly. Short-term antibiotic exposure did not result in critical mutations that convert class 2 integrons into functional forms.

Keywords: Class 2 integron, recA, Resistance genes, Integrase gene, Sub-MIC, antibiotic

Received: 21 May 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Ye, Sun, Wu, Xu, Yang, Zhao and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Qingcao Li, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.